Prebiotic‐Based Nanoamorphous Atorvastatin Attenuates Nonalcoholic Fatty Liver Disease by Retrieving Gut and Liver Health
Small structures, 2023-08, Vol.4 (8), p.n/a [Peer Reviewed Journal]2023 Wiley‐VCH GmbH ;2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2688-4062 ;EISSN: 2688-4062 ;DOI: 10.1002/sstr.202370020
Digital Resources/Online E-Resources